Effect of Adipose Derived Stem Cells on Survival of Fat as Filler
1 other identifier
interventional
15
1 country
1
Brief Summary
this research is to study the effect of Adipose Derived Stem Cells on Survival of Fat as Filler
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
May 24, 2019
CompletedFirst Posted
Study publicly available on registry
May 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 16, 2019
CompletedJuly 18, 2019
July 1, 2019
7 months
May 24, 2019
July 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment using hollowness severity rating scale :0 : no visible hollowness, 1: mild Hollowness, 2 : moderate Hollowness, 3: severe Hollowness
serial photography for assessment using hollowness severity rating scale :0 : no visible hollowness, 1: mild Hollowness, 2 : moderate Hollowness, 3: severe Hollowness
3 months, 6 months
Secondary Outcomes (2)
Measurement of hypodermal thickness in mm using UBM (Ultrasound Bio microscopy) on both temple regions of the head
3 months, 6 months
Measurement of dermal thickness in mm using UBM (Ultrasound Bio microscopy) on both temple regions of the head Measurement of dermal thickness in mm using UBM (Ultrasound Bio microscopy) on both temple regions of the head
3 months, 6 months
Study Arms (2)
lipofilling
PLACEBO COMPARATORsubcutaneous injection of lipoaspiate (microfat) in one temporal region
lipofilling enriched with adipose tissue derived stem cells
ACTIVE COMPARATORsubcutaneous injection of lipoaspiate enriched with adipose tissue derived stem cells in one temporal region
Interventions
Under local anesthesia using strict aseptic technique, a small incision will be done in the lateral aspect of the thigh or lower abdomen, through which the infiltration cannula will be introduced to inject the local anesthetic solution using the wet technique. This will be followed 15 minutes later by lipo-aspiration of 75 ml fat ) using a blunt tipped cannula under the negative suction pressure of a 60 ml syringe. 50 ml is used for preparation of microfat. then with blunt cannula,subcutaneous injection of the required volume of microfat is placed into temporal region.
Under local anesthesia using strict aseptic technique, a small incision will be done in the lateral aspect of the thigh or lower abdomen, through which the infiltration cannula will be introduced to inject the local anesthetic solution using the wet technique. This will be followed 15 minutes later by lipo-aspiration of 75 ml fat using a blunt tipped cannula under the negative suction pressure of a 60 ml syringe. 50 ml is used for preparation of microfat. 25 ml is used for preparation of autologous adipose tissue derived stem cells (At-ADSCs) using enzymatic digestion and differential centrifugation in the Center of Excellence for Research in Regenerative Medicine and its Application (CERRMA), Alexandria Faculty of Medicine. Subcutaneous injection of the required volume of microfat combined with stromal vascular fraction containing adipose tissue derived stem cells, is placed into temporal region.
Eligibility Criteria
You may qualify if:
- Clinically diagnosed facial skin aging.
- Glogau photoaging score II and III.
- Body mass index ≥20 with adequate abdominal or other subcutaneous adipose tissue accessible for lipoaspiration.
You may not qualify if:
- History of keloid formation.
- Any coincidental chronic illness (e.g. metabolic, autoimmune or endocrinal) or malignancy.
- Any bleeding or coagulation disorder or recent use of anticoagulant therapy.
- Active infection.
- History of any previous aesthetic procedure on the face within the past 6 months.
- History of intake of anti-aging systemic or topical medications within the previous 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aliaa Ismail
Alexandria, 21521, Egypt
Related Publications (1)
Roshdy OH, Abdallah WI, Farid CI, Mehanna RA, Bayoumi NH, Ismail AI. Stromal vascular fraction improves the durability of autologous fat temple augmentation-A split-face randomized study using ultrasound biomicroscopy. J Plast Reconstr Aesthet Surg. 2022 Jun;75(6):1870-1877. doi: 10.1016/j.bjps.2021.12.005. Epub 2022 Jan 15.
PMID: 35125305DERIVED
Study Officials
- STUDY DIRECTOR
Carmen Ibrahim Farid Mohammed Amin, MD
Assistant Professor of Dermatology, Faculty of Medicine, Alexandria University.
- STUDY DIRECTOR
Ossama Hussein Roshdy, MD
Professor of Dermatology, Faculty of Medicine, University of Alexandria.
- STUDY DIRECTOR
Wafaa Ibrahim Abdullah, MD
Professor of Dermatology, Faculty of Medicine, University of Alexandria.
- STUDY DIRECTOR
Radwa Ali Mehanna, PhD
Assistant Professor of Physiology, Faculty of Medicine, Alexandria University
- STUDY DIRECTOR
Nader Hussein Lotfy Bayoumi., MD, FRCS
Professor of ophthalmology , Faculty of Medicine, University of Alexandria.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
May 24, 2019
First Posted
May 29, 2019
Study Start
January 1, 2019
Primary Completion
July 16, 2019
Study Completion
July 16, 2019
Last Updated
July 18, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share